Rheumatology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063962
  • May 2021
  • Pharmaceuticals
  • 132 Pages
The Rheumatology Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered AbbVie Inc., Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., Amgen Inc., Novartis AG, Janssen Pharmaceuticals, Inc., Sanofi, Genentech, Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd, UCB S.A., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Eli Lilly and Company, Qiagen NV, Euro Diagnostica AB, Antibodies Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Rheumatology market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Rheumatology market is expected to attain Pre COVID-19 levels by mid-2022.

Rheumatology Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Rheumatology market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Rheumatology Market Competitive and Premeditated Analysis
In the Rheumatology report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Rheumatology research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Rheumatology Market:
The Rheumatology market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. AbbVie Inc., Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., Amgen Inc., Novartis AG, Janssen Pharmaceuticals, Inc., Sanofi, Genentech, Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd, UCB S.A., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Eli Lilly and Company, Qiagen NV, Euro Diagnostica AB, Antibodies Inc.

The Rheumatology market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Rheumatology Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Rheumatology market:
By Drug Class
Nonsteroidal Anti-Inflammatory Drugs
NSAIDs
Corticosteroids
Uric Acid Drugs
Disease Modifying Anti-Rheumatic Drugs
DMARDs
Disease Indication
Rheumatoid Arthritis
Osteoarthritis
Gout
Psoriatic Arthritis
Ankylosing Spondylitis
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Regional Analysis of the Rheumatology market:
The Rheumatology market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Rheumatology report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Rheumatology market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Rheumatology market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Rheumatology market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Rheumatology market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Rheumatology market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Rheumatology market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Rheumatology market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Rheumatology market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Amgen Inc.
  • Novartis AG
  • Janssen Pharmaceuticals, Inc.
  • Sanofi
  • Genentech, Inc.
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson Private Limited
  • F. Hoffmann-La Roche Ltd
  • UCB S.A.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim International GmbH
  • Regeneron Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Qiagen NV
  • Euro Diagnostica AB
  • Antibodies Inc.
  • Nonsteroidal Anti-Inflammatory Drugs
  • NSAIDs
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Rheumatology Market Snapshot
          2.1.1. Global Rheumatology Market By Drug Class,2019
               2.1.1.1.Nonsteroidal Anti-Inflammatory Drugs
               2.1.1.2.NSAIDs
          2.1.2. Global Rheumatology Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacy
               2.1.2.2.Retail Pharmacy
               2.1.2.3.Online Pharmacy
          2.1.3. Global Rheumatology Market By End-use,2019
          2.1.4. Global Rheumatology Market By Geography,2019

3. Global Rheumatology Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Rheumatology Market Size (US$), By Drug Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Class, 2020
     4.2. Global Rheumatology Market Size (US$), By Drug Class, 2018 – 2028

5. Global Rheumatology Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Rheumatology Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Rheumatology Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Rheumatology Market Size (US$), By End-use, 2018 – 2028

7. Global Rheumatology Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Rheumatology Market Analysis, 2018 – 2028 
          7.2.1. North America Rheumatology Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Rheumatology Market Size (US$), By Drug Class, 2018 – 2028
          7.2.3. North America Rheumatology Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Rheumatology Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Rheumatology Market Analysis, 2018 – 2028 
          7.3.1.  Europe Rheumatology Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Rheumatology Market Size (US$), By Drug Class, 2018 – 2028
          7.3.3. Europe Rheumatology Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Rheumatology Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Rheumatology Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Rheumatology Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Rheumatology Market Size (US$), By Drug Class, 2018 – 2028
          7.4.3. Asia Pacific Rheumatology Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Rheumatology Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Rheumatology Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Rheumatology Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Rheumatology Market Size (US$), By Drug Class, 2018 – 2028
          7.5.3. Latin America Rheumatology Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Rheumatology Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Rheumatology Market Analysis, 2018 – 2028 
          7.6.1.  MEA Rheumatology Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Rheumatology Market Size (US$), By Drug Class, 2018 – 2028
          7.6.3. MEA Rheumatology Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Rheumatology Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Rheumatology Providers
        8.4.1 AbbVie Inc.
                8.4.1.1 Business Description
                8.4.1.2 AbbVie Inc. Geographic Operations
                8.4.1.3 AbbVie Inc. Financial Information
                8.4.1.4 AbbVie Inc. Product Positions/Portfolio
                8.4.1.5 AbbVie Inc. Key Developments
        8.4.2 Bristol-Myers Squibb Company
                8.4.2.1 Business Description
                8.4.2.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.2.3 Bristol-Myers Squibb Company Financial Information
                8.4.2.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.2.5 Bristol-Myers Squibb Company Key Developments
        8.4.3 Pfizer Inc.
                8.4.3.1 Business Description
                8.4.3.2 Pfizer Inc. Geographic Operations
                8.4.3.3 Pfizer Inc. Financial Information
                8.4.3.4 Pfizer Inc. Product Positions/Portfolio
                8.4.3.5 Pfizer Inc. Key Developments
        8.4.4 Merck & Co., Inc.
                8.4.4.1 Business Description
                8.4.4.2 Merck & Co., Inc. Geographic Operations
                8.4.4.3 Merck & Co., Inc. Financial Information
                8.4.4.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.4.5 Merck & Co., Inc. Key Developments
        8.4.5 Amgen Inc.
                8.4.5.1 Business Description
                8.4.5.2 Amgen Inc. Geographic Operations
                8.4.5.3 Amgen Inc. Financial Information
                8.4.5.4 Amgen Inc. Product Positions/Portfolio
                8.4.5.5 Amgen Inc. Key Developments
        8.4.6 Novartis AG
                8.4.6.1 Business Description
                8.4.6.2 Novartis AG Geographic Operations
                8.4.6.3 Novartis AG Financial Information
                8.4.6.4 Novartis AG Product Positions/Portfolio
                8.4.6.5 Novartis AG Key Developments
        8.4.7 Janssen Pharmaceuticals, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Janssen Pharmaceuticals, Inc. Geographic Operations
                8.4.7.3 Janssen Pharmaceuticals, Inc. Financial Information
                8.4.7.4 Janssen Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.7.5 Janssen Pharmaceuticals, Inc. Key Developments
        8.4.8 Sanofi
                8.4.8.1 Business Description
                8.4.8.2 Sanofi Geographic Operations
                8.4.8.3 Sanofi Financial Information
                8.4.8.4 Sanofi Product Positions/Portfolio
                8.4.8.5 Sanofi Key Developments
        8.4.9 Genentech, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Genentech, Inc. Geographic Operations
                8.4.9.3 Genentech, Inc. Financial Information
                8.4.9.4 Genentech, Inc. Product Positions/Portfolio
                8.4.9.5 Genentech, Inc. Key Developments
        8.4.10 Takeda Pharmaceutical Company Limited
                8.4.10.1 Business Description
                8.4.10.2 Takeda Pharmaceutical Company Limited Geographic Operations
                8.4.10.3 Takeda Pharmaceutical Company Limited Financial Information
                8.4.10.4 Takeda Pharmaceutical Company Limited Product Positions/Portfolio
                8.4.10.5 Takeda Pharmaceutical Company Limited Key Developments
        8.4.11 Johnson & Johnson Private Limited
                8.4.11.1 Business Description
                8.4.11.2 Johnson & Johnson Private Limited Geographic Operations
                8.4.11.3 Johnson & Johnson Private Limited Financial Information
                8.4.11.4 Johnson & Johnson Private Limited Product Positions/Portfolio
                8.4.11.5 Johnson & Johnson Private Limited Key Developments
        8.4.12 F. Hoffmann-La Roche Ltd
                8.4.12.1 Business Description
                8.4.12.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.12.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.12.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.12.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.13 UCB S.A.
                8.4.13.1 Business Description
                8.4.13.2 UCB S.A. Geographic Operations
                8.4.13.3 UCB S.A. Financial Information
                8.4.13.4 UCB S.A. Product Positions/Portfolio
                8.4.13.5 UCB S.A. Key Developments
        8.4.14 Gilead Sciences, Inc.
                8.4.14.1 Business Description
                8.4.14.2 Gilead Sciences, Inc. Geographic Operations
                8.4.14.3 Gilead Sciences, Inc. Financial Information
                8.4.14.4 Gilead Sciences, Inc. Product Positions/Portfolio
                8.4.14.5 Gilead Sciences, Inc. Key Developments
        8.4.15 Boehringer Ingelheim International GmbH
                8.4.15.1 Business Description
                8.4.15.2 Boehringer Ingelheim International GmbH Geographic Operations
                8.4.15.3 Boehringer Ingelheim International GmbH Financial Information
                8.4.15.4 Boehringer Ingelheim International GmbH Product Positions/Portfolio
                8.4.15.5 Boehringer Ingelheim International GmbH Key Developments
        8.4.16 Regeneron Pharmaceuticals Inc.
                8.4.16.1 Business Description
                8.4.16.2 Regeneron Pharmaceuticals Inc. Geographic Operations
                8.4.16.3 Regeneron Pharmaceuticals Inc. Financial Information
                8.4.16.4 Regeneron Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.16.5 Regeneron Pharmaceuticals Inc. Key Developments
        8.4.17 Eli Lilly and Company
                8.4.17.1 Business Description
                8.4.17.2 Eli Lilly and Company Geographic Operations
                8.4.17.3 Eli Lilly and Company Financial Information
                8.4.17.4 Eli Lilly and Company Product Positions/Portfolio
                8.4.17.5 Eli Lilly and Company Key Developments
        8.4.18 Qiagen NV
                8.4.18.1 Business Description
                8.4.18.2 Qiagen NV Geographic Operations
                8.4.18.3 Qiagen NV Financial Information
                8.4.18.4 Qiagen NV Product Positions/Portfolio
                8.4.18.5 Qiagen NV Key Developments
        8.4.19 Euro Diagnostica AB
                8.4.19.1 Business Description
                8.4.19.2 Euro Diagnostica AB Geographic Operations
                8.4.19.3 Euro Diagnostica AB Financial Information
                8.4.19.4 Euro Diagnostica AB Product Positions/Portfolio
                8.4.19.5 Euro Diagnostica AB Key Developments
        8.4.20 Antibodies Inc.
                8.4.20.1 Business Description
                8.4.20.2 Antibodies Inc. Geographic Operations
                8.4.20.3 Antibodies Inc. Financial Information
                8.4.20.4 Antibodies Inc. Product Positions/Portfolio
                8.4.20.5 Antibodies Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Rheumatology Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Rheumatology Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Rheumatology Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Rheumatology Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Rheumatology Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Rheumatology Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Rheumatology Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Rheumatology Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Rheumatology Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Rheumatology Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Rheumatology Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Rheumatology Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Rheumatology Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Rheumatology Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Rheumatology Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Rheumatology Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Rheumatology: Market Segmentation 
FIG. 2 Global Rheumatology Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Rheumatology Market, By Drug Class, 2019 (US$ Mn) 
FIG. 5 Global Rheumatology Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Rheumatology Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Rheumatology Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Rheumatology Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Rheumatology Providers, 2019
FIG. 11 Global Rheumatology Market Revenue Contribution, By Drug Class, 2019 & 2028 (Value %) 
FIG. 12 Global Rheumatology Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Rheumatology Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Rheumatology Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Rheumatology Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Rheumatology Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Rheumatology Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Rheumatology Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Rheumatology market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Rheumatology Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Rheumatology Market Value, By Segment1, 2018 – 2028
TABLE  North America Rheumatology Market Value, By Segment2, 2018 – 2028
TABLE  North America Rheumatology Market Value, By Country, 2018 – 2028
TABLE  Europe Rheumatology Market Value, By Segment1, 2018 – 2028
TABLE  Europe Rheumatology Market Value, By Segment2, 2018 – 2028
TABLE  Europe Rheumatology Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Rheumatology Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Rheumatology Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Rheumatology Market Value, By Country, 2018 – 2028
TABLE  Latin America Rheumatology Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Rheumatology Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Rheumatology Market Value, By Country, 2018 – 2028
TABLE  MEA Rheumatology Market Value, By Segment1, 2018 – 2028
TABLE  MEA Rheumatology Market Value, By Segment2, 2018 – 2028
TABLE  MEA Rheumatology Market Value, By Country, 2018 – 2028
TABLE  AbbVie Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Janssen Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genentech, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical Company Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson Private Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  UCB S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Regeneron Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qiagen NV: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Euro Diagnostica AB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Antibodies Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Rheumatology Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Rheumatology Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Rheumatology Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Rheumatology Market, By Geography, 2019 (US$ Mn)
FIG.  Global Rheumatology Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Rheumatology Providers, 2016
FIG.  Global Rheumatology Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global NSAIDs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Rheumatology Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Rheumatology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Rheumatology Market Value, 2018 – 2028, (US$ Mn)